Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier
- 14 June 2010
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 78 (3), 376-383
- https://doi.org/10.1124/mol.110.063685
Abstract
ATP-driven efflux transporters at the blood-brain barrier both protect against neurotoxicants and limit drug delivery to the brain. In other barrier and excretory tissues, efflux transporter expression is regulated by certain ligand-activated nuclear receptors. Here we identified constitutive androstane receptor (CAR) as a positive regulator of P-glycoprotein, multidrug resistance-associated protein 2 (Mrp2), and breast cancer resistance protein (BCRP) expression in rat and mouse brain capillaries. Exposing rat brain capillaries to the CAR activator, phenobarbital (PB), increased the transport activity and protein expression (Western blots) of P-glycoprotein, Mrp2, and BCRP. Induction of transport was abolished by the protein phosphatase 2A inhibitor, OA. Similar effects on transporter activity and expression were found when mouse brain capillaries were exposed to the mouse-specific CAR ligand, 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). In brain capillaries from CAR-null mice, TCPOBOP did not increase transporter activity. Finally, treating mice with 0.33 mg/kg TCPOBOP or rats with 80 mg/kg PB increased P-glycoprotein-, Mrp2-, and BCRP-mediated transport and protein expression in brain capillaries assayed ex vivo. Thus, CAR activation selectively tightens the blood-brain barrier by increasing transport activity and protein expression of three xenobiotic efflux pumps.Keywords
This publication has 36 references indexed in Scilit:
- Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse liversBMC Genomics, 2009
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2009
- Nuclear receptors as therapeutic targets in cholestatic liver diseasesBritish Journal of Pharmacology, 2008
- Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in MicePharmaceutical Research, 2008
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood–brain barrierNeurochemistry International, 2008
- CAR and PXR: The xenobiotic-sensing receptors☆Steroids, 2006
- Phenytoin Induction of the Cyp2c37 Gene Is Mediated by the Constitutive Androstane ReceptorPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-RegulationMolecular Pharmacology, 2006
- Expression of Constitutive Androstane Receptor Splice Variants in Human Tissues and Their Functional ConsequencesJournal of Pharmacology and Experimental Therapeutics, 2004